TSPAN17
gene geneOn this page
Also known as FBX23
Summary
TSPAN17 (tetraspanin 17, HGNC:13594) is a protein-coding gene on chromosome 5q35.2, encoding Tetraspanin-17 (Q96FV3). Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10.
This gene encodes a member of the transmembrane 4 superfamily. It is characterized by four tetraspanin transmembrane segments. The function of this gene has not yet been determined.
Source: NCBI Gene 26262 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_130465
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13594 |
| Approved symbol | TSPAN17 |
| Name | tetraspanin 17 |
| Location | 5q35.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FBX23 |
| Ensembl gene | ENSG00000048140 |
| Ensembl biotype | protein_coding |
| OMIM | 620446 |
| Entrez | 26262 |
Gene structure
Transcript identifiers
Ensembl transcripts: 26 — 24 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000298564, ENST00000310032, ENST00000503030, ENST00000503045, ENST00000504168, ENST00000507471, ENST00000508164, ENST00000514705, ENST00000515708, ENST00000860608, ENST00000860609, ENST00000860610, ENST00000860611, ENST00000860612, ENST00000860613, ENST00000860614, ENST00000917608, ENST00000917609, ENST00000917610, ENST00000917611, ENST00000917612, ENST00000917613, ENST00000917614, ENST00000917615, ENST00000956721, ENST00000956722
RefSeq mRNA: 5 — MANE Select: NM_130465
NM_001006616, NM_001366491, NM_001366492, NM_012171, NM_130465
CCDS: CCDS34298, CCDS47346, CCDS54952
Canonical transcript exons
ENST00000508164 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001219135 | 176654895 | 176655020 |
| ENSE00001716853 | 176647484 | 176647702 |
| ENSE00002036859 | 176657518 | 176659051 |
| ENSE00003484462 | 176652743 | 176652913 |
| ENSE00003494752 | 176651616 | 176651666 |
| ENSE00003517507 | 176656700 | 176656816 |
| ENSE00003518006 | 176651754 | 176651900 |
| ENSE00003667839 | 176656078 | 176656125 |
| ENSE00003785372 | 176656895 | 176656956 |
Expression profiles
Bgee: expression breadth ubiquitous, 250 present calls, max score 92.84.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 22.2253 / max 253.2741, expressed in 1800 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 60432 | 20.9534 | 1799 |
| 60431 | 1.2719 | 949 |
Top tissues by expression
258 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right adrenal gland | UBERON:0001233 | 92.84 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 92.77 | gold quality |
| pancreatic ductal cell | CL:0002079 | 92.38 | gold quality |
| left adrenal gland | UBERON:0001234 | 92.34 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 92.24 | gold quality |
| adrenal cortex | UBERON:0001235 | 92.12 | gold quality |
| cerebellar vermis | UBERON:0004720 | 91.49 | gold quality |
| adrenal gland | UBERON:0002369 | 91.45 | gold quality |
| granulocyte | CL:0000094 | 91.24 | gold quality |
| upper arm skin | UBERON:0004263 | 90.98 | silver quality |
| ileal mucosa | UBERON:0000331 | 90.89 | gold quality |
| apex of heart | UBERON:0002098 | 90.73 | gold quality |
| gastrocnemius | UBERON:0001388 | 90.65 | gold quality |
| stromal cell of endometrium | CL:0002255 | 90.64 | gold quality |
| tibialis anterior | UBERON:0001385 | 90.38 | silver quality |
| muscle of leg | UBERON:0001383 | 90.12 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 89.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 89.67 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 89.62 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 89.49 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 89.32 | gold quality |
| adrenal tissue | UBERON:0018303 | 89.32 | gold quality |
| right frontal lobe | UBERON:0002810 | 89.06 | gold quality |
| heart left ventricle | UBERON:0002084 | 88.87 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 88.76 | gold quality |
| cardiac ventricle | UBERON:0002082 | 88.60 | gold quality |
| adenohypophysis | UBERON:0002196 | 88.52 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 88.40 | gold quality |
| kidney epithelium | UBERON:0004819 | 88.35 | silver quality |
| metanephros cortex | UBERON:0010533 | 88.35 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.07 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
54 targeting TSPAN17, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-3158-5P | 99.65 | 67.51 | 1763 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-6848-3P | 99.64 | 66.49 | 885 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-4687-3P | 99.48 | 66.41 | 968 |
| HSA-MIR-766-3P | 99.47 | 65.24 | 1811 |
| HSA-MIR-6080 | 99.43 | 69.43 | 373 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-6843-3P | 99.26 | 66.42 | 915 |
| HSA-MIR-422A | 99.18 | 65.83 | 550 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
| HSA-MIR-6830-5P | 99.01 | 68.73 | 1884 |
| HSA-MIR-5701 | 98.97 | 69.54 | 1502 |
| HSA-MIR-520G-3P | 98.91 | 67.38 | 1914 |
| HSA-MIR-520H | 98.91 | 67.38 | 1914 |
| HSA-MIR-760 | 98.81 | 66.65 | 1392 |
| HSA-MIR-6840-3P | 98.68 | 65.95 | 1923 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-4680-3P | 98.64 | 68.60 | 2093 |
| HSA-MIR-4726-3P | 98.49 | 63.89 | 1385 |
| HSA-MIR-378A-3P | 98.43 | 66.10 | 548 |
Literature-anchored findings (GeneRIF, showing 2)
- Endothelial Tspan5- and Tspan17-ADAM10 complexes may regulate inflammation by maintaining normal VE-cadherin expression and promoting T lymphocyte transmigration. (PMID:28600292)
- Data suggested that increased miR378a3p and decreased TSPAN17 levels were associated with improved survival in glioblastoma multiforme (GBM). Additionally, high levels of TSPAN17 were linked to the poor prognosis of patients with GBM aged 5060, larger tumor sizes and an advanced World Health Organization stage. TSPAN17 was identified and confirmed as a direct target of miR378a. (PMID:31432186)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tspan17 | ENSDARG00000114067 |
| mus_musculus | Tspan17 | ENSMUSG00000025875 |
| rattus_norvegicus | Tspan17 | ENSRNOG00000018122 |
Paralogs (32): TSPAN6 (ENSG00000000003), CD9 (ENSG00000010278), TSPAN9 (ENSG00000011105), TSPAN32 (ENSG00000064201), CD82 (ENSG00000085117), TSPAN15 (ENSG00000099282), CD37 (ENSG00000104894), UPK1A (ENSG00000105668), TSPAN12 (ENSG00000106025), TSPAN13 (ENSG00000106537), TSPAN14 (ENSG00000108219), CD81 (ENSG00000110651), TSPAN11 (ENSG00000110900), PRPH2 (ENSG00000112619), UPK1B (ENSG00000114638), TSPAN1 (ENSG00000117472), TSPAN8 (ENSG00000127324), TSPAN16 (ENSG00000130167), TSPAN2 (ENSG00000134198), CD63 (ENSG00000135404), TSPAN31 (ENSG00000135452), TSPAN3 (ENSG00000140391), CD53 (ENSG00000143119), ROM1 (ENSG00000149489), TSPAN7 (ENSG00000156298), TSPAN18 (ENSG00000157570), TSPAN33 (ENSG00000158457), TSPAN5 (ENSG00000168785), CD151 (ENSG00000177697), TSPAN10 (ENSG00000182612), TSPAN4 (ENSG00000214063), TSPAN19 (ENSG00000231738)
Protein
Protein identifiers
Tetraspanin-17 — Q96FV3 (reviewed: Q96FV3)
Alternative names: F-box only protein 23, Tetraspan protein SB134, Transmembrane 4 superfamily member 17
All UniProt accessions (6): Q96FV3, D6RBW9, D6RDX8, D6RI03, H0Y9A5, J3KNG2
UniProt curated annotations — full annotation on UniProt →
Function. Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10. This interaction is required for ADAM10 exit from the endoplasmic reticulum and for enzymatic maturation and trafficking to the cell surface as well as substrate specificity. Different TspanC8/ADAM10 complexes have distinct substrates. Seems to regulate VE-cadherin expression in endothelial cells probably through interaction with ADAM10, promoting leukocyte transmigration.
Subunit / interactions. Interacts with ADAM10; the interaction influences ADAM10 substrate specificity, endocytosis and turnover.
Subcellular location. Cell membrane.
Similarity. Belongs to the tetraspanin (TM4SF) family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96FV3-1 | 1 | yes |
| Q96FV3-3 | 2 | |
| Q96FV3-2 | 3 | |
| Q96FV3-4 | 4 |
RefSeq proteins (5): NP_001006617, NP_001353420, NP_001353421, NP_036303, NP_569732* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000301 | Tetraspanin_animals | Family |
| IPR008952 | Tetraspanin_EC2_sf | Homologous_superfamily |
| IPR018499 | Tetraspanin/Peripherin | Family |
| IPR018503 | Tetraspanin_CS | Conserved_site |
Pfam: PF00335
UniProt features (23 total): topological domain 5, splice variant 5, disulfide bond 4, transmembrane region 4, glycosylation site 2, chain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96FV3-F1 | 88.48 | 0.72 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (4): 155–223, 156–188, 172–182, 189–202
Glycosylation sites (2): 51, 171
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 116 (showing top):
GOBP_MACROMOLECULE_CATABOLIC_PROCESS, IVANOVA_HEMATOPOIESIS_MATURE_CELL, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GGGTGGRR_PAX4_03, CATRRAGC_UNKNOWN, MCBRYAN_PUBERTAL_BREAST_4_5WK_DN, GOBP_REGULATION_OF_CATABOLIC_PROCESS, AML_Q6, HFH8_01, TCF11_01, FOXJ2_01, HFH4_01, GOBP_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS, HFH3_01, GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS
GO Biological Process (3): intracellular protein localization (GO:0008104), regulation of membrane protein ectodomain proteolysis (GO:0051043), establishment of protein localization to organelle (GO:0072594)
GO Molecular Function (1): enzyme binding (GO:0019899)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| macromolecule localization | 1 |
| membrane protein ectodomain proteolysis | 1 |
| regulation of proteolysis | 1 |
| regulation of protein catabolic process | 1 |
| establishment of protein localization | 1 |
| protein binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
880 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TSPAN17 | ADAM10 | O14672 | 759 |
| TSPAN17 | TSPAN31 | Q12999 | 666 |
| TSPAN17 | TSPAN13 | O95857 | 578 |
| TSPAN17 | TSPAN12 | O95859 | 493 |
| TSPAN17 | CSNK1A1 | P48729 | 491 |
| TSPAN17 | TSPAN16 | Q9UKR8 | 392 |
| TSPAN17 | ZNF727 | A8MUV8 | 380 |
| TSPAN17 | CFAP68 | Q9H5F2 | 370 |
| TSPAN17 | SCG5 | P01164 | 363 |
| TSPAN17 | TSPAN32 | Q96QS1 | 349 |
| TSPAN17 | TSPAN1 | O60635 | 338 |
| TSPAN17 | ADAM17 | P78536 | 338 |
| TSPAN17 | CDH17 | Q12864 | 321 |
| TSPAN17 | FBXO34 | Q9NWN3 | 318 |
| TSPAN17 | FAM43B | Q6ZT52 | 317 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TSPAN17 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.530 |
| ADAM10 | TSPAN17 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TSPAN17 | MGST3 | psi-mi:“MI:0914”(association) | 0.350 |
| TSPAN17 | HACD3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TSPAN17 | UBA1 | psi-mi:“MI:0220”(ubiquitination reaction) | 0.000 |
BioGRID (119): TSPAN17 (Affinity Capture-RNA), ADAM10 (Affinity Capture-Western), ATP2A3 (Affinity Capture-MS), PNPLA6 (Affinity Capture-MS), DGKE (Affinity Capture-MS), TBL2 (Affinity Capture-MS), RETSAT (Affinity Capture-MS), DHRS7 (Affinity Capture-MS), TYW1 (Affinity Capture-MS), GHDC (Affinity Capture-MS), AGPAT4 (Affinity Capture-MS), SLC44A1 (Affinity Capture-MS), AGPAT3 (Affinity Capture-MS), ACVR1B (Affinity Capture-MS), CYP51A1 (Affinity Capture-MS)
ESM2 similar proteins: O43657, O46101, O60635, O70352, O70401, O97703, P08962, P19075, P19331, P19397, P24485, P27591, P27701, P28648, P35762, P40237, P41731, P41732, P60033, P60034, P62079, P62080, Q17QJ5, Q26499, Q28709, Q2KIS9, Q32KU6, Q3T0S3, Q3ZCD0, Q4R7W6, Q4V8E0, Q58DM3, Q58DN3, Q5R9S6, Q5RAS5, Q5RC27, Q61451, Q62283, Q62745, Q68VK5
Diamond homologs: A1L157, B5X3I6, O14817, O35566, O60636, O70352, P19075, P24485, P27701, P40241, P48509, P60033, P60034, P61170, P61171, Q0VC33, Q3ZBH3, Q4V8E0, Q568Y5, Q58CY8, Q58DN3, Q5R9S6, Q5RAP3, Q61451, Q80WR1, Q8WMQ3, Q96FV3, Q96SJ8, Q9D1D1, Q9D7W4, Q9DCK3, Q9JJW1, Q9QZA6, F7BWT7, O95858, P62079, P62080, Q17QJ5, Q1JQA4, Q3SYV5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1549 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:176647700:TGGG:T | donor_loss | 1.0000 |
| 5:176647701:GG:G | donor_gain | 1.0000 |
| 5:176647702:GG:G | donor_gain | 1.0000 |
| 5:176647702:GGT:G | donor_loss | 1.0000 |
| 5:176647703:G:GG | donor_gain | 1.0000 |
| 5:176647704:T:A | donor_loss | 1.0000 |
| 5:176651897:GTTT:G | donor_gain | 1.0000 |
| 5:176651901:G:GG | donor_gain | 1.0000 |
| 5:176652757:C:A | acceptor_gain | 1.0000 |
| 5:176652908:GAA:G | donor_gain | 1.0000 |
| 5:176652914:G:GG | donor_gain | 1.0000 |
| 5:176654891:ACAGT:A | acceptor_gain | 1.0000 |
| 5:176654892:CAG:C | acceptor_loss | 1.0000 |
| 5:176654893:A:AG | acceptor_gain | 1.0000 |
| 5:176654893:A:AT | acceptor_loss | 1.0000 |
| 5:176654893:AGT:A | acceptor_gain | 1.0000 |
| 5:176654893:AGTG:A | acceptor_gain | 1.0000 |
| 5:176654894:G:GT | acceptor_gain | 1.0000 |
| 5:176654894:GT:G | acceptor_gain | 1.0000 |
| 5:176654894:GTG:G | acceptor_gain | 1.0000 |
| 5:176654894:GTGG:G | acceptor_gain | 1.0000 |
| 5:176654894:GTGGT:G | acceptor_gain | 1.0000 |
| 5:176656076:AGGAG:A | acceptor_gain | 1.0000 |
| 5:176656077:GGAGG:G | acceptor_gain | 1.0000 |
| 5:176656122:ACTGG:A | donor_loss | 1.0000 |
| 5:176656126:G:GG | donor_gain | 1.0000 |
| 5:176656127:T:G | donor_loss | 1.0000 |
| 5:176656132:GGG:G | donor_gain | 1.0000 |
| 5:176656133:GGG:G | donor_gain | 1.0000 |
| 5:176656697:CAG:C | acceptor_loss | 1.0000 |
AlphaMissense
2168 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000153661 (5:176648525 C>T), RS1000214522 (5:176653799 T>C), RS1000275022 (5:176651335 A>G), RS1000401913 (5:176646544 C>T), RS1000486767 (5:176659273 C>T), RS1000756279 (5:176659089 C>T), RS1000770271 (5:176656982 C>T), RS1001076636 (5:176657152 T>C), RS1001402098 (5:176654677 G>A), RS1001686584 (5:176647466 G>A,C), RS1001947858 (5:176649899 A>C,G), RS1002176958 (5:176651377 G>A), RS1002207935 (5:176651105 G>A), RS1002303937 (5:176650170 G>A), RS1002592874 (5:176647773 G>A)
Disease associations
OMIM: gene MIM:620446 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009921_4 | Carotid intima media thickness (mean) | 3.000000e-12 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| bufotalin | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | increases abundance, decreases expression | 1 |
| nickel sulfate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| jinfukang | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Cisplatin | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.